Structure

InChI Key NWIUTZDMDHAVTP-UHFFFAOYSA-N
Smiles CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1
InChI
InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H29NO3
Molecular Weight 307.43
AlogP 2.39
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 11.0
Polar Surface Area 50.72
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 22.0
Assay Description Organism Bioactivity Reference
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria Cavia porcellus 1.738 nM
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria None 125.89 nM
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-2 adrenergic receptor in calf lung membranes. None 657.0 nM
In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha Cavia porcellus 104.71 nM
In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea Cavia porcellus 104.71 nM
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart Canis lupus familiaris 37.1 nM
Compound was tested for the biological activity at the Beta-1 adrenergic receptor Cavia porcellus 39.81 nM
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations Cavia porcellus 1.738 nM
Antagonist activity against beta-1 adrenergic receptor (unknown origin) Homo sapiens 1.585 nM
Antagonist activity at rat beta1 adrenoceptor Rattus norvegicus 2.951 nM
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 18.67 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.03 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.03 %

Related Entries

Cross References

Resources Reference
ChEBI 3082
ChEMBL CHEMBL423
DrugBank DB00195
DrugCentral 356
FDA SRS O0ZR1R6RZ2
Human Metabolome Database HMDB0014341
Guide to Pharmacology 549
KEGG C06849
PharmGKB PA448611
PubChem 2369
SureChEMBL SCHEMBL23530